Experimental study demonstrates high-throughput sorting of full-length antibodies from single yeast clones, highlighting rapid target-specific enrichment for therapeutic discovery.
, our new platform is capable of screening millions of antibodies per day and enriching for target-specific ones in 4 days. This platform will enable the efficient screening of antibody libraries in a variety of contexts, including primary screening of synthetic libraries, affinity maturation, and identification of multi-specific or cross-reactive antibodies.
No takes yet. Share an insight, caveat, or question.
Lebrun et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: